James A. Schoeneck
2020 - FibroGen
In 2020, James A. Schoeneck earned a total compensation of $717.3K as Interim Chief Executive Officer at FibroGen, a 86% decrease compared to previous year.
Compensation breakdown
| Salary | $200,000 |
|---|---|
| Other | $517,343 |
| Total | $717,343 |
Schoeneck received $517.3K in other compensation, accounting for 72% of the total pay in 2020.
Schoeneck also received $200K in salary.
Rankings
In 2020, James A. Schoeneck's compensation ranked 9,895th out of 13,090 executives tracked by ExecPay. In other words, Schoeneck earned more than 24.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,895 out of 13,090 | 24th |
Division Manufacturing | 4,252 out of 5,620 | 24th |
Major group Chemicals And Allied Products | 1,748 out of 2,253 | 22nd |
Industry group Drugs | 1,531 out of 1,953 | 22nd |
Industry Pharmaceutical Preparations | 1,130 out of 1,458 | 23rd |
Pay ratio
| James A. Schoeneck's Pay | $717,343 |
|---|---|
| Median Employee's Pay | $177,952 |
| Pay Ratio | 4to 1 |
In 2020, the annual total compensation of James A. Schoeneck was $717,343.
The annual total compensation of the median employee at FibroGen was $177,952.
The ratio of James A. Schoeneck's pay to the pay of median employee was therefore 4 to one.
Source: SEC filing on April 13, 2021.
Schoeneck's colleagues
We found seven more compensation records of executives who worked with James A. Schoeneck at FibroGen in 2020.
2020
Enrique Conterno
FibroGen
Chief Executive Officer
2020
Thane Wettig
FibroGen
Chief Commercial Officer
2020
Mark Eisner
FibroGen
Chief Medical Officer
2020
K Yu
FibroGen
Chief Medical Officer
2020
Pat Cotroneo
FibroGen
Chief Financial Officer
2020
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
2020
Christine Chung
FibroGen